HIVMA : View All Increased Federal Funding Comments

03/13/2013

Written Testimony to the House for Fiscal Year 2014 Appropriations

Testimony submitted for the record to the House Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies regarding FY2014 funding levels for HIV/AIDS Programs, submitted by Dr. Michael Horberg on behalf of the HIV Medicine Association.

12/07/2012

IDSA-HIVMA letter to the Office of Management and Budget on funding priorities for FY2014

HIVMA and IDSA leaders weighed in with the White House Office of Management and Budget (OMB) on federal funding priorities for fiscal year 2014. The joint letter to the OMB urges sustained investments in ID and HIV research and public health activities; development of new drugs, vaccines and diagnostics; and provision of high quality health care to reduce health care costs while saving lives and improving quality of life.

09/10/2012

IDSA-HIVMA Letter Opposing Sequestration

HIVMA and IDSA leaders weighed in with Congress, urging action to prevent “sequestration”—across the board cuts to all federal agencies—from occurring before January 1, 2013. The letter highlights the devastating impact such cuts would have for the nation’s public health infrastructure and biomedical research enterprise, which have already borne a disproportionate share of budget cuts in recent years.

06/07/2012

HIVMA Comments in Advance of Committee Action on the Senate FY2013 LHHS and Education Appropriations Bill

HIVMA Board Chair, Dr. Judith A. Aberg, weighed in with Senate appropriators on behalf of HIVMA, in anticipation of Committee action on the Senate FY2013 Labor, Health and Human Services and Education appropriations bill next week. The letter urges the highest possible levels of funding for key domestic and international HIV/AIDS programs.

03/28/2012

Written Testimony to the House for Fiscal Year 2013 Appropriations

Testimony Submitted for the Record to the Subcommittee on Labor, Health and Human Services, Education and Related Agencies on FY 2013 Appropriations for HIV/AIDS Programs Submitted by the HIV Medicine Association

10/13/2011

HIVMA and IDSA urge Congress to not eliminate the U.S. Military HIV Research Program

IDSA & HIVMA sent a letter expressing grave concern about the proposed elimination of the $16 million Army Science and Technology funding line of the U.S. Military HIV Research Program (MHRP).

09/09/2011

Implications of HPTN 052 for the US Response to Domestic and Global AIDS

HIVMA responds to the results of the HPTN 052 study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), which found that HIV-infected men and women with relatively healthy immune systems who received immediate oral antiretroviral therapy (ART) were more than 96 percent less likely to sexually transmit the infection to their uninfected partners and were more than 40 percent less likely to experience a clinical event than those whose treatment was delayed.

09/08/2011

View All Increased Federal Funding Comments

Written Testimony to the House for Fiscal Year 2014 Appropriations

IDSA-HIVMA letter to the Office of Management and Budget on funding priorities for FY2014

IDSA-HIVMA Letter Opposing Sequestration

HIVMA Comments in Advance of Committee Action on the Senate FY2013 LHHS and Education Appropriations Bill

Written Testimony to the House for Fiscal Year 2013 Appropriations

HIVMA and IDSA urge Congress to not eliminate the U.S. Military HIV Research Program

Implications of HPTN 052 for the US Response to Domestic and Global AIDS

HIVMA Urges Super Committee to Protect our nation's public health and health care safety-net

Joint Budget Statement of IDSA and HIVMA

HIVMA Testimony to the Senate for Fiscal Year 2012 Appropriations

HIVMA Testimony to the House for Fiscal Year 2012 Appropriations

IDSA, HIVMA Support Repeal of 20 Year-Old Ban on Needle Exchange

HIV Physician Scientists and Advocacy Groups Urge Secretary Kerry to Advocate For Funding for PEPFAR and the Global Fund

HIV Medicine Association